PYPD

PolyPid Ltd. Ordinary Shares (PYPD)

About PolyPid Ltd. Ordinary Shares (PYPD)

PolyPid Ltd. operates as a phase 3 biopharma company. Its proprietary PLEX technology pairs with medications, enables precise delivery of drugs at effective release rates, over pre-determined durations ranging from several days to months. The firm's product candidates are designed to address unmet medical needs by delivering active pharmaceutical ingredients, or APIs, locally at predetermined release rates and durations over extended periods ranging from days to several months. The company was founded by Noam Emanuel on February 28, 2008 and is headquartered in Petach Tikva, Israel.

Details

Daily high
$3.62
Daily low
$3.54
Price at open
$3.62
52 Week High
$9.20
52 Week Low
$2.95
Market cap
24.4M
Dividend yield
0.00%
Volume
1,346
Avg. volume
4,647
P/E ratio
-.36

PolyPid Ltd. Ordinary Shares News

Details

Daily high
$3.62
Daily low
$3.54
Price at open
$3.62
52 Week High
$9.20
52 Week Low
$2.95
Market cap
24.4M
Dividend yield
0.00%
Volume
1,346
Avg. volume
4,647
P/E ratio
-.36